Gsk Share Discussion Threads

[tradermichael] 28/6/2018 14:49

I have been expecting this to be 50p higher by now …… ;0)

[tradermichael] 27/6/2018 08:55

According to a report in The Economic Times, Coca Cola has mandated Citi to help them in the competitive bidding process expected to be launched next week to buy the manufacturer of famous brand Horlicks.

Nestle, Danone and HUL among other firms are also eyeing GlaxoSmithKline's consumer nutrition business.

Consumer healthcare products of GlaxoSmithKline Consumer Healthcare include Horlicks, Boost, and Maltova among others.

[nico9] 27/6/2018 06:50

Hopefully a blue open then

[ny boy] 27/6/2018 00:01

Share market update: Glaxo Consumer jumps over 6% on Coke bid to buy parent firm unit

Read more at:

[imastu pidgitaswell] 26/6/2018 10:16

Nah, 1500. Just a little dip below, and have to say I didn't think it would - early days though.

[action] 26/6/2018 08:12

New support at 1470 now

[romeike] 25/6/2018 15:46

You can't look at GSK in isolation of events, look at the FTSE today, GSK following the herd for now. But the fact is pharma is heavily isolated from trade war shenanigans and will recover much faster than the more cycle dependant stocks. Look for any opportunity to add if things turn really sour.

[rlivsey] 25/6/2018 15:21

There was always going to be a pullback but this is rather unpleasant

[davemac3] 25/6/2018 15:12

blame Donaldo, he's not after the ballon d'or, he's after the ballon de merde

[action] 25/6/2018 14:03

bk to 1490 ?

[action] 25/6/2018 13:28

down even after recent good updates?

[action] 25/6/2018 13:21

Under support level 1517p

[ianood] 22/6/2018 17:27

I prefer to ignore Motley Fool

[jrphoenixw2] 22/6/2018 11:17

This is a pretty '1.01 article' but I did find the 5-year look-back over some core lines in the accounts created a pretty concise picture. FWIW The article concludes:
'Overall, I score GlaxoSmithKline 10 out of 15, which makes me a little cautious about the sustainability of the firm’s dividend, particularly with the ongoing drag from generic competition. The static dividend demonstrates how tough things have been for the firm and I’m not expecting the dividend to rise much over the next year or two. That said, I think GlaxoSmithKline could be a decent stock to hold for very patient investors because of the defensive characteristics of the sector.'


[Ignore the usual x-sales puffery at the end]

[tradermichael] 22/6/2018 11:13

My view is don't jump! The price is bound to ease back momentarily before resuming this recovery.

The extra contribution from the Novartis deal is starting to kick in, there's continued good new product news and some of the competition worries have eased, prolonging revenue from older products.

[garycook] 22/6/2018 09:17

Where is NY Boy ?

[imastu pidgitaswell] 22/6/2018 09:14

Oooh, have I done something right, offloading some at 1580+?

Some fairly clear support at this level, straight line across etc. Have reinvested the sale proceeds in SAGA, so won't be adding them back here yet, but still have plenty. Just come up a long way from 1250 odd, needed some sort of pullback.


free stock charts from uk.advfn.com

[supermarky] 22/6/2018 08:39

Clever boy.

[abdullla] 22/6/2018 08:37

Down from 1587!

[supermarky] 22/6/2018 08:24

Thanks guys

[tradermichael] 21/6/2018 15:03

Yes, and reflecting drop in whole FTSE

[zho] 21/6/2018 14:58

supermarky - it might be a reaction to sterling spiking up a cent at noon, presumably a reaction to the MPC announcement. See

[supermarky] 21/6/2018 14:47

Whats with the drop at 12 noon?